Replies to post #293696 on Avid Bioservices Inc (CDMO)

[nuke661]

Masshysteria,

At the last quarterly conference call it was stated that some patients in sunrise are still receiving Bavi. We now know that a significant number of the PIII Bavi arm patients went on to Keytruda or Opdivo (based on the p values they are stating in this press release),

I'm wondering if there is the chance of a de-facto Bavi + (Keytruda or Opdivo) trial going on. Is there a possibility that the PIII Bavi arm patients who progressed to other immunotherapy treatments would also be allowed to continue to take Bavi at the same time as part of the compassionate use program?

Thanks in advance for your input